Moncyte targets optimal cholesterol-lowering therapy
Moncyte R&D team from University of Helsinki has developed a unique solution that sheds light on why some people respond differently to cholesterol-lowering drugs.
We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.